Lyon

With more than 1,500 employees, the Lyon area is now Boehringer Ingelheim's center of activity in France, and home to six of the company’s ten French sites. The French headquarters and the animal health headquarters are located in the life sciences district of Lyon. 

In this area, Boehringer Ingelheim is present across the entire animal health value chain: research and development, production, and supply of veterinary products. Since 2015, more than €500 million have been invested into Lyon’s R&D and production sites.

The Grand Lyon industrial biologic center is one of the largest supply centers in Boehringer Ingelheim’s global network. It combines three core facilities:

• Lyon-Porte-des-Alpes, an R&D center of excellence, and production center for veterinary vaccines.
• Lentilly, a center dedicated to the filling, visual inspection, packaging and storage of veterinary vaccines.
• Jonage, a future production site for veterinary active ingredients, which represents a major investment of €355 million and will be operational in 2026.

One additional site nearby Lyon is Saint-Vulbas, a clinical research center for veterinary vaccines and pharmaceutical products.